Skip to main content
    O

    OraSure Technologies Inc (OSUR)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $3.81
    +0.10 (+2.70%)

    Market Cap: $255.87M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    64%(25/39)
    Avg Surprise
    +44.32%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.18
    Range$-0.18 - $-0.18
    1 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.13-37.0%
    60d ago$-0.15-23.0%
    30d ago$-0.15-23.0%
    7d ago$-0.15-23.0%
    Current$-0.18
    Revenue Consensus
    $31M
    Range$31M - $31M
    1 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.23
    Range$-0.23 - $-0.23
    1 analysts
    Revenue Consensus
    $34M
    Range$34M - $34M
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.23---
    Sep 26EST
    		-$-0.18---
    Jun 26
    Reported Aug 5
    		$-0.23$-0.22-4.55%Miss-21.1%
    Mar 26
    Reported May 6
    		$-0.24$-0.17-41.18%Miss-33.3%
    Dec 25
    Reported Feb 25
    		$-0.19$-0.19+0.00%Beat-216.7%
    Sep 25
    Reported Nov 5
    		$-0.17$-0.20+15.00%Beat-1600.0%
    Jun 25
    Reported Aug 5
    		$-0.19$-0.15-26.67%Miss-371.4%
    Mar 25
    Reported May 7
    		$-0.18$-0.12-50.00%Miss-550.0%
    Dec 24
    Reported Feb 25
    		$-0.06$-0.01-460.75%Miss-122.2%
    Sep 24
    Reported Nov 6
    		$-0.01$-0.02+50.00%Beat-103.7%
    Jun 24
    Reported Aug 6
    		$0.07$0.03+133.33%Beat-22.2%
    Mar 24
    Reported May 8
    		$0.04$0.03+33.33%Beat-91.5%
    Dec 23
    Reported Feb 27
    		$0.27$0.09+200.00%Beat-25.0%
    Sep 23
    Reported Nov 7
    		$0.27$0.08+237.50%Beat+107.7%
    Jun 23
    Reported Aug 3
    		$0.09$-0.08+212.50%Beat+325.0%
    Mar 23
    Reported May 10
    		$0.47$0.14+235.71%Beat+267.9%
    Dec 22
    Reported Feb 14
    		$0.36$0.04+800.00%Beat+357.1%
    Sep 22
    Reported Nov 8
    		$0.13$0.03+333.33%Beat+159.1%
    Jun 22
    Reported Aug 9
    		$-0.04N/A+63.64%Beat-100.0%
    Mar 22
    Reported May 10
    		$-0.28$-0.13-115.38%Miss-660.0%
    Dec 21
    Reported Feb 23
    		$-0.14$-0.13-7.69%Miss-566.7%
    Sep 21
    Reported Nov 3
    		$-0.22$-0.05-340.00%Miss-2300.0%
    Jun 21
    Reported Aug 3
    		$-0.02$0.04-150.00%Miss+88.2%
    Mar 21
    Reported May 5
    		$0.05$0.03+66.67%Beat+150.0%
    Dec 20
    Reported Mar 1
    		$0.03N/A-57.14%Miss-50.0%
    Sep 20
    Reported Nov 4
    		$0.01N/A+116.67%Beat-66.7%
    Jun 20
    Reported Aug 5
    		$-0.17$-0.07-142.86%Miss-342.9%
    Mar 20
    Reported May 6
    		$-0.10$-0.05-100.00%Miss-400.0%
    Dec 19
    Reported Feb 19
    		$0.06$0.07-14.29%Miss-70.0%
    Sep 19
    Reported Nov 6
    		$0.03N/A-76.92%Miss-76.9%
    Jun 19
    Reported Aug 6
    		$0.07$0.03+133.33%Beat-36.4%
    Mar 19
    Reported May 8
    		$-0.02N/A+66.67%Beat-128.6%
    Dec 18
    Reported Feb 6
    		$0.20$0.11+81.82%Beat+66.7%
    Sep 18
    Reported Nov 7
    		$0.13$0.11+18.18%Beat+44.4%
    Jun 18
    Reported Aug 8
    		$0.11$0.07+57.14%Beat+22.2%
    Mar 18
    Reported May 2
    		$0.07$0.05+40.00%Beat+40.0%
    Dec 17
    Reported Feb 7
    		$0.12$0.11+9.09%Beat-7.7%
    Sep 17
    Reported Nov 1
    		$0.09$0.09+0.00%Beat-
    Jun 17
    Reported Aug 2
    		$0.09$0.07+28.57%Beat-
    Mar 17
    Reported May 3
    		$0.05$-0.03+266.67%Beat-
    Dec 16
    Reported Feb 8
    		$0.13$0.06+116.67%Beat-

    Key Metrics

    Valuation
    P/E Ratio-4.59EV/EBITDAN/A
    Price/FCF-5.47xFCF Yield-18.28%
    Profitability
    Profit Margin-43.70%Operating Margin-56.00%
    ROE-14.10%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio8.88xQuick Ratio7.68x
    Trading Statistics
    Beta1.02Avg Volume567.89K
    52-Week High$4.5852-Week Low$2.08

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$3.85
    SMA 20$3.86
    SMA 50$3.74
    SMA 200$3.44
    EMA 10$3.82
    EMA 20$3.81
    EMA 50$3.79
    EMA 200$3.54

    MACD

    Line: 0.03Signal: 0.04Hist: -0.01

    ADX

    ADX: 15.6+DI: 21.3-DI: 26.7

    Aroon & PSAR

    Aroon Up72.0
    Aroon DownN/A
    PSAR$4.02

    Bollinger Bands

    Upper Band$4.12
    Lower Band$3.60
    %B Position1327%(Upper)
    Band Width0.40

    RSI (14-Day)

    Neutral
    50.6

    Momentum Oscillators

    Stoch %K29.8
    Stoch %D38.9
    Williams %R-63.6
    ROC (10d)-1.8%
    Momentum-0.07
    CCI (20d)-53.7
    MFI (14d)68.2

    Volatility Measures

    ATR (14d)$0.16(4.2%)
    StdDev (20d)0.13
    Hist Vol54.1%(High)

    Volume Flow

    VWAP$3.78
    OBV10.9M
    AD Line-6.8M
    CMF (20d)0.102

    Volume Metrics

    Avg Vol (20d)586.1K
    Vol Ratio1.0x
    VWMA (20d)$3.84

    Pivot Points

    R3$3.88
    R2$3.84
    R1$3.78
    Pivot Point$3.74
    S1$3.68
    S2$3.64
    S3$3.58

    Advanced Oscillators

    TSI4.75
    Ultimate Osc45.2
    KST67.28

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$30.64M$27.93M$26.76M$27.09M$31.24M$29.93M$37.45M$39.91M$54.34M$54.13M$75.88M$89.19M
    Cost of Revenue$17.32M$16.12M$15.79M$15.31M$18.08M$17.63M$23.88M$22.84M$29.65M$30.07M$40.76M$44.85M
    Gross Profit$13.32M$11.80M$10.97M$11.77M$13.16M$12.30M$13.57M$17.07M$24.69M$24.07M$35.13M$44.34M
    Operating Expenses$7.88M$35.07M$31.07M$27.86M$31.18M$30.05M$25.98M$23.07M$27.43M$31.16M$31.23M$33.45M
    R&D$9.44M$13.65M$11.42M$10.11M$11.40M$9.60M$6.09M$5.62M$6.60M$7.74M$6.99M$8.52M
    SG&A$14.43M$14.56M$9.82M$11.08M$12.68M$14.10M$12.90M$9.83M$11.85M$11.63M$14.01M$10.05M
    Operating Income$5.44M$-23,269,000$-20,103,000$-16,090,000$-18,026,000$-17,750,000$-12,418,000$-5,999,000$-2,740,000$-7,093,000$3.90M$10.89M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$6.82M$-21,721,000$-18,432,000$-13,291,000$-16,891,000$-15,972,000$-9,507,000$-3,218,000$326,000$-3,602,000$20.72M$13.51M
    Income Tax Expense$55,000$-432,000$210,000$47,000$2.00M$-456,000$758,000$678,000$381,000$-18,000$647,000$2.35M
    Net Income$6.25M$-22,377,000$-19,286,000$-13,712,000$-19,693,000$-16,040,000$-10,794,000$-4,507,000$-615,000$-3,584,000$20.07M$11.16M
    EBITDA$6.35M$-19,462,000$-16,030,000$-10,910,000$-17,360,000$-13,201,000$-7,010,000$-650,000$2.84M$-871,000$24.28M$16.87M
    EBIT$6.82M$-21,721,000$-18,432,000$-13,291,000$-16,891,000$-15,972,000$-9,507,000$-3,218,000$326,000$-3,602,000$20.72M$13.51M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about OSUR

    Government Contracts

    Gov Obligations (TTM)
    $387972
    Gov Obligations / Revenue
    0.3%
    Obligations YoY
    N/A
    Active Awards
    14
    New Awards (TTM)
    0
    Avg Remaining Term
    10.2 mo

    Top agency: Department of Health and Human Services at 100.0% of trailing twelve month obligations across 1 agencies

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    OraSure Technologies stock trades above USD 3.00 consensus target

    OraSure Technologies stock is trading above its USD 3.00 consensus target, despite the target being 21.47 percent below its Nasdaq quote. The company reported improved second-quarter margins with revenue of USD 30.64...

    ad-hoc-news.de•10/15/26•Somewhat-Bullish

    Islet engages OraSure board. OraSure Technologies stock gains 1.80 percent

    Islet Management engaged OraSure Technologies on September 17, 2026, regarding potential board changes, including one or more directors. OraSure reported second-quarter 2026 revenue of USD 30.6 million and a 43.5 percent...

    AD HOC NEWS•10/8/26•Somewhat-Bullish

    OraSure Technologies stock gets fresh insider grant of 4,797 shares

    OraSure Technologies (OSUR) saw a director, Steven Kyle Boyd, granted 4,797 restricted common shares as compensation...

    AD HOC NEWS•10/7/26•Neutral

    Islet Management engages OraSure on board changes for OraSure Technologies stock

    Islet Management has engaged OraSure Technologies' board and management regarding stockholder value and potential board changes. This engagement follows a significantly improved second quarter for OraSure...

    AD HOC NEWS•10/2/26•Neutral

    A 4,797-share grant replaces cash fees for OraSure (OSUR) director Steven Kyle Boyd.

    OraSure Technologies director Steven Kyle Boyd acquired 4,797 common shares on September 29, 2026, at $3.88 per share. These restricted shares, which vested immediately...

    Stock Titan•10/1/26•Neutral

    OSUR Valuation and Fair Value

    P/E
    -4.6x
    Forward P/E
    40.0x
    P/FCF
    -5.5x
    PEG
    6.2x
    P/B
    0.8x
    See GNG's fair value

    OSUR Profitability: Margins, ROIC and FCF

    Gross margin
    42.6%
    Operating margin
    -56.0%
    Net margin
    -43.7%
    ROE
    -14.1%
    FCF margin
    -42.8%
    FCF yield
    -18.3%

    OSUR Competitors

    CompanyTicker
    EyePoint, IncEYPT
    Vanda Pharmaceuticals IncVNDA
    Prelude Therapeutics IncPRLD
    Inhibikase Therapeutics IncIKT
    Palisade Bio IncPALI
    Century Therapeutics IncIPSC
    Standard Biotools IncLAB
    BioAge Labs, IncBIOA

    Sector: Healthcare

    OSUR Bull Case vs Bear Case

    Bear case

    • OSUR has a -43.7% net profit margin.
    • OSUR beat EPS estimates in 25.0% of its last 8 reported quarters.
    • OSUR's quarterly revenue changed -1.9% year over year.

    OSUR Earnings: Beat Rate and Next Report

    Beat rate
    2 of 8 quarters (25.0%)
    Average surprise
    -64.8%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.18
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 0 down

    Frequently Asked Questions About OSUR

    Does OSUR pay dividends?

    OraSure Technologies Inc (OSUR) does not currently pay a regular dividend.

    What is OSUR's market cap?

    OraSure Technologies Inc (OSUR) has a market capitalization of $255.87M with a current stock price of $3.81.

    Related stocks

    Sector: Healthcare

    All stocks starting with O

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In